Moringa Acquisition Corp
moringaac.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q2 FY2024 10-Q, filed Aug 13, 2024. Its latest SEC filing is a SCHEDULE 13G/A from Aug 27, 2024.
10-Q for Q2 FY2024, filed Aug 13, 2024
The sections below describe the company as of the FY2023 annual report.
What Did They Do?
Provides target businesses a route to become publicly traded through a merger or similar business combination.
How Did They Make Money?
No revenue was reported.
10-K for FY2023, filed Apr 1, 2024
How Were They Changing?
- Net income
-
Sources
10-Q for Q2 FY2024, filed Aug 13, 2024
−$110.6KView ↗
- ▼ Now a loss
- vs $162.9K in Q2 FY2023
-
Aug 21, 2024
Completed its business combination with Silexion
Silexion became a wholly owned subsidiary of the new public company, and Moringa's securities were slated for delisting.
Sources
8-K, filed Aug 21, 2024
As discussed in the Introductory Note, which is incorporated into this Item 2.01 by reference, effective as of the Closing Date, Moringa…View ↗
From broad search to a named target
The older report describes a search for Israel-related technology businesses; the latest report says Moringa pursued Holisto and then focused exclusively on Silexion.
10-K for FY2020, filed Mar 31, 2021 10-K for FY2023, filed Apr 1, 2024We are a blank check company formed on September 24, 2020 as a Cayman Islands exempted company and formed for the purpose of effecting a…View ↗
Loading...
